BSE Live
Dec 31, 16:00Prev. Close
134.45
Open Price
133.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 31, 15:59Prev. Close
134.45
Open Price
134.00
Bid Price (Qty.)
134.45 (41)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Sun Pharma Advanced Research Company (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -1.04 | -0.44 | -0.24 | -0.26 | -0.07 | |
| Diluted EPS (Rs.) | -1.04 | -0.44 | -0.24 | -0.26 | -0.07 | |
| Cash EPS (Rs.) | -0.92 | -0.35 | -0.17 | -0.25 | -0.07 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 0.68 | 1.72 | 2.16 | 2.57 | 0.93 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 0.68 | 1.72 | 2.16 | 2.57 | 0.93 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 1.66 | 1.70 | 1.81 | 0.00 | 0.00 | |
| PBDIT/Share (Rs.) | -0.91 | -0.50 | -0.16 | -0.09 | -0.07 | |
| PBIT/Share (Rs.) | -1.03 | -0.59 | -0.22 | -0.09 | -0.07 | |
| PBT/Share (Rs.) | -1.04 | -0.60 | -0.22 | -0.09 | -0.07 | |
| Net Profit/Share (Rs.) | -1.04 | -0.44 | -0.24 | -0.26 | -0.07 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -54.58 | -29.62 | -8.75 | 0.00 | 0.00 | |
| PBIT Margin (%) | -62.14 | -34.85 | -12.14 | 0.00 | 0.00 | |
| PBT Margin (%) | -62.64 | -35.54 | -12.17 | 0.00 | 0.00 | |
| Net Profit Margin (%) | -62.64 | -26.01 | -13.03 | 0.00 | 0.00 | |
| Return on Networth / Equity (%) | -152.59 | -25.61 | -10.89 | -10.02 | -7.06 | |
| Return on Capital Employed (%) | -68.86 | -18.55 | -10.04 | -9.43 | -7.06 | |
| Return on Assets (%) | -24.69 | -12.16 | -7.88 | -9.01 | -6.60 | |
| Total Debt/Equity (X) | 0.15 | 0.05 | 0.01 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 39.41 | 46.76 | 60.52 | 0.00 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.17 | 0.17 | 2.13 | 10.50 | 15.15 | |
| Quick Ratio (X) | 0.17 | 0.17 | 2.13 | 10.50 | 15.15 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,060.69 | 1,089.59 | 1,742.16 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 59.89 | 31.01 | 46.50 | 0.00 | 0.00 | |
| EV/EBITDA (X) | -109.72 | -104.65 | -531.05 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 59.99 | 30.97 | 46.50 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 146.14 | 30.51 | 38.87 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 59.99 | 30.97 | 46.50 | 0.00 | 0.00 | |
| Earnings Yield | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y